Rolph Timothy
Akero Therapeutics, Inc. · Chief Scientific Officer
Rolph Timothy is listed in filings as Chief Scientific Officer at Akero Therapeutics, Inc.. This profile follows SEC Form 4 activity through Dec 9, 2025, including sale activity. Recent filings connect the profile to Akero Therapeutics, Inc. (AKRO). The current snapshot covers public activity from Mar 7, 2025 to Dec 9, 2025. Reported amounts are shown as $3.6M to $1.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $527k11.5k shares | SellOct 7, 2025 | $46.01 | $54.65 | |
| $49k1k shares | SellOct 7, 2025 | $46.82 | $54.65 |